Annexon (ANNX) Cash & Equivalents (2019 - 2026)

Annexon's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $175.2 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 78.5% year-over-year to $175.2 million in Q1 2026; TTM through Mar 2026 was $175.2 million, a 78.5% increase from a year earlier, with the FY2025 full-year figure at $160.0 million, up 216.72% from the prior year.
• Cash & Equivalents climbed to $175.2 million in Q1 2026 per ANNX's latest filing, from $160.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $226.1 million in Q4 2023 and bottomed at $583000.0 in Q1 2022.
• The 5-year median for Cash & Equivalents is $139.4 million (2025), against an average of $131.0 million.
• Across the five-year window, Cash & Equivalents slumped 99.72% in 2022 and soared 24797.43% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $141.1 million in 2022, then surged by 60.33% to $226.1 million in 2023, then tumbled by 77.66% to $50.5 million in 2024, then jumped by 216.72% to $160.0 million in 2025, then grew by 9.48% to $175.2 million in 2026.
• Per Business Quant, the three latest ANNX Cash & Equivalents figures stand at $175.2 million (Q1 2026), $160.0 million (Q4 2025), and $139.4 million (Q3 2025).